
Vanlige spørsmål om cystisk fibrose
Vanlige spørsmål om cystisk fibrose
References
-
Orenstein DM. Cystic Fibrosis: A Guide for Patient and Family. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
-
Derichs N. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. European Respiratory Review. 2013;22(127):58-65.
-
Wang W, Linsdell P. Conformational change opening the CFTR chloride channel pore coupled to ATP-dependent gating. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2012;1818(3):851-860.
-
MacDonald K, McKenzie K, Zeitlin P. Cystic Fibrosis Transmembrane Regulator Protein Mutations. Pediatric Drugs. 2007;9(1):1-10.
-
NHS Choices website.
-
Cystic Fibrosis Foundation website.
-
World Health Organization website.
-
Farrell P. The prevalence of cystic fibrosis in the European Union. Journal of Cystic Fibrosis 7. 2008:450-453
-
O'Sullivan B, Freedman S. Cystic fibrosis. The Lancet. 2009;373(9678):1891-1904.
-
The Clinical and Functional Translation of CFTR (CFTR2) website.
-
Welsh MJ, Ramsey BW, Accurso F, Cutting GR. Cystic fibrosis: membrane transport disorders. In: Valle D, Beaudet A, Vogelstein B et al. eds. The Online Metabolic & Molecular Bases of Inherited Disease. The McGraw-Hill Companies Inc; 2004:part 21, chap 201.
-
Borowitz D, et al. Consensus Report on Nutrition for Paediatric Patients With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2002;35(3):246-59.
-
Smyth A, et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014;13:S23–S42.